{"id":"W2022301990","doi":"10.1016/j.cgh.2010.04.021","title":"Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab","year":2010,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"UCB Pharma; National Cancer Institute","keywords":"Certolizumab pegol; Medicine; Infliximab; Internal medicine; Maintenance therapy; Crohn's disease; Gastroenterology; Surgery; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004546272,0.0004263239,0.001068437,0.0006435313,0.0006084948,0.0007311751,0.000239246,0.0009176387,0.001407459],"category_scores_gemma":[0.002241709,0.0002739078,0.0007622641,0.0006462516,0.0003912378,0.0005794336,0.0004035847,0.0009427574,0.0001964799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003423215,"about_ca_system_score_gemma":0.0003837163,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001450288,"about_ca_topic_score_gemma":0.002607231,"domain_scores_codex":[0.99962,0.0001134097,0.00005401428,0.00004953595,0.0000532477,0.0001097747],"domain_scores_gemma":[0.9991295,0.0002634447,0.0002006096,0.00002935953,0.00004359805,0.0003335603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.007321366,0.000222549,0.9782212,0.00006232259,0.0001678293,0.005264952,0.0001051056,0.0001094507,0.0007421682,0.00004052825,0.0003915686,0.007350928],"study_design_scores_gemma":[0.000523996,0.002079468,0.9879984,0.00002728761,0.0002111071,0.007621618,0.0002532072,0.0004220143,0.0001664576,0.0001123156,0.0005689673,0.0000151202],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996426,0.001480045,0.00004511875,0.0003356955,0.00004313987,0.00001239759,0.00008292643,0.000005938692,0.001568625],"genre_scores_gemma":[0.9993069,0.000233834,0.00003198683,0.0001425608,0.00006242347,0.000005484872,0.00009495414,0.000001223075,0.0001205796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001450288,"threshold_uncertainty_score":0.00470835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005757835295310622,"score_gpt":0.2482573645422792,"score_spread":0.2424995292469686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}